dr. mesa on late-stage trials in myelofibrosis
Published 11 years ago • 1.1K plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:13
dr. mesa on new trials and agents in the pipeline in myelofibrosis
-
1:36
dr. mesa gives an overview of upcoming trials in myelofibrosis
-
0:57
dr. mesa on challenges in myelofibrosis treatment
-
1:16
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
1:48
dr. mesa on pacritinib for myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
2:13
dr. mesa on the efficacy of fedratinib in patients with myelofibrosis and low platelet counts
-
1:52
dr. mesa on investigative therapies in myelofibrosis
-
1:32
dr. mesa on emerging therapies in myelofibrosis
-
30:30
dr ruben mesa-myelofibrosis and advancing mpns: current and future approaches
-
2:34
dr. mesa on ruxolitinib in myelofibrosis
-
2:03
dr. mesa on jakarta-2 reanalysis for myelofibrosis
-
55:50
drs. mesa, jamieson, & mascarenhas discuss #myelofibrosis during #asco23 - https://bit.ly/45niv2g
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
5:33
ruben mesa, md: momelotinib non-inferior to ruxolitinib in myelofibrosis
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis
-
1:18
dr. ruben mesa discusses the comfort ruxolitinib trials
-
2:10
dr. verstovsek on accelerated phase myelofibrosis